FDA Inspection 880494 — Robert L. Findling, M.D.
The FDA completed an inspection of Robert L. Findling, M.D. on May 1, 2014 in Baltimore, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 1, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Baltimore, MD (United States)
Additional Details
Clinical Investigator (CI)